Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 3/20 | 0.40 |
| ▸ | PPARG | P37231 | 2/20 | 0.40 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.38 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.38 |
| ▸ | S1PR4 | O95977 | 2/20 | 0.38 |
| ▸ | S1PR5 | Q9H228 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | THRA | P10827 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.35 |
| ▸ | PRKCG | P05129 | 1/20 | 0.35 |
| ▸ | PRKCB | P05771 | 1/20 | 0.35 |
| ▸ | PRKCA | P17252 | 1/20 | 0.35 |
| ▸ | PRKCH | P24723 | 1/20 | 0.35 |
| ▸ | PRKCI | P41743 | 1/20 | 0.35 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2011162 | 0.92 | PPARA (0.42) | PPARAPPARGS1PR1S1PR3S1PR4 | |
| SCHEMBL1471074 | 0.87 | S1PR1 (0.36) | PPARAPPARGS1PR1S1PR3S1PR4 | |
| SCHEMBL2805053 | 0.86 | PPARA (0.47) | PPARAPPARGS1PR1S1PR3S1PR4 | |
| SCHEMBL13954369 | 0.84 | ALDH1A1 (0.36) | MEN1MAPTKMT2ATHRBCYP2C9 | |
| SCHEMBL2285244 | 0.84 | S1PR1 (0.37) | PPARAPPARGS1PR1S1PR3S1PR4 | |
| SCHEMBL2283157 | 0.81 | S1PR1 (0.54) | PPARAPPARGS1PR1S1PR3S1PR4 | |
| SCHEMBL2283468 | 0.80 | PPARA (0.43) | PPARAPPARGS1PR1S1PR3S1PR4 | |
| SCHEMBL2008551 | 0.79 | S1PR1 (0.46) | PPARAPPARGS1PR1S1PR3S1PR4 | |
| SCHEMBL2011165 | 0.75 | PRKCG (0.35) | PPARAPPARGS1PR1S1PR3S1PR4 | |
| SCHEMBL14206102 | 0.74 | S1PR1 (0.42) | PPARAPPARGS1PR1S1PR3S1PR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8173710-B2 | Bicyclic sphingosine 1-phosphate analogs | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2012-05-08 | — | — | US | disclosed |
| US-8173710-B2 | Bicyclic sphingosine 1-phosphate analogs | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2012-05-08 | — | — | US | disclosed |
| US-20110195936-A1 | BICYCLIC SPHINGOSINE 1-PHOSPHATE ANALOGS | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2011-08-11 | — | — | US | disclosed |
| US-20110195936-A1 | BICYCLIC SPHINGOSINE 1-PHOSPHATE ANALOGS | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2011-08-11 | — | — | US | disclosed |
| US-20100240617-A1 | BICYCLIC SPHINGOSINE 1-PHOSPHATE ANALOGS | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2010-09-23 | — | — | US | disclosed |
| US-20100240617-A1 | BICYCLIC SPHINGOSINE 1-PHOSPHATE ANALOGS | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2010-09-23 | — | — | US | disclosed |
| EP-2190852-A1 | BICYCLIC SPHINGOSINE 1-PHOSPHATE ANALOGS | University Of Virginia Patent Foundation (US) | 2010-06-02 | — | — | EP | disclosed |
| WO-2009023854-A1 | BICYCLIC SPHINGOSINE 1-PHOSPHATE ANALOGS | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2009-02-19 | — | — | WO | disclosed |
| US-20090042955-A1 | BICYCLIC SPHINGOSINE 1-PHOSPHATE ANALOGS | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2009-02-12 | — | — | US | disclosed |
| US-20090042955-A1 | BICYCLIC SPHINGOSINE 1-PHOSPHATE ANALOGS | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2009-02-12 | — | — | US | disclosed |
| EP-1987013-A1 | BICYCLIC SPHINGOSINE 1-PHOSPHATE ANALOGS | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2008-11-05 | — | — | EP | disclosed |
| WO-2007092638-A1 | BICYCLIC SPHINGOSINE 1-PHOSPHATE ANALOGS | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2007-08-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090042955-A1 | BICYCLIC SPHINGOSINE 1-PHOSPHATE ANALOGS | S1PR1, S1PR4, S1PR3 | PPARA 1155/4885PPARG 1650/4885S1PR1 1/4885 |
| US-20110195936-A1 | BICYCLIC SPHINGOSINE 1-PHOSPHATE ANALOGS | S1PR1, S1PR4, S1PR3 | PPARA 1155/4885PPARG 1650/4885S1PR1 1/4885 |
| US-20100240617-A1 | BICYCLIC SPHINGOSINE 1-PHOSPHATE ANALOGS | S1PR1, S1PR4, S1PR3 | PPARA 1155/4885PPARG 1650/4885S1PR1 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.